LRIG1 antibody [C2C3], C-term
GTX119485
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetLRIG1
Overview
- SupplierGeneTex
- Product NameLRIG1 antibody [C2C3], C-term
- Delivery Days Customer9
- ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.61 mg/ml
- ConjugateUnconjugated
- Gene ID26018
- Target nameLRIG1
- Target descriptionleucine rich repeats and immunoglobulin like domains 1
- Target synonymsLIG-1, LIG1, leucine-rich repeats and immunoglobulin-like domains protein 1, leucine-rich repeat protein LRIG1, ortholog of mouse integral membrane glycoprotein LIG-1
- HostRabbit
- IsotypeIgG
- Protein IDQ96JA1
- Protein NameLeucine-rich repeats and immunoglobulin-like domains protein 1
- Scientific DescriptionAct as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Hsu HL, Chen HK, Tsai CH, et al. Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR Degradation. Int J Mol Sci. 2021,22(18). doi: 10.3390/ijms22189988Read this paper
- Yokdang N, Hatakeyama J, Wald JH, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016,35(22):2932-47. doi: 10.1038/onc.2015.345Read this paper







